If You Invested $2,000 in Moderna Stock in 2019, This Is How Much You Would Have Today

If You Invested $2,000 in Moderna Stock in 2019, This Is How Much You Would Have Today
·5 min read

Moderna (NASDAQ: MRNA) is one of the hottest biotechs on the market thanks to its rapid development of a functional coronavirus vaccine. With an abundance of fanfare, Moderna went public in late 2018, and it was the largest biotech initial public offering (IPO) in history at the time. In particular, management had already started to accentuate critical capabilities like the potential for rapid and inexpensive research and development (R&D) compared with that necessary for older non-mRNA vaccine technologies like modified adenoviruses.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting